THE WOODLANDS, Texas--(BUSINESS WIRE)--The US Oncology Network (The Network), the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced today that Tennessee Cancer Specialists (TCS) has joined The Network, effective August 1, 2024. The practice is the largest community-based oncology provider in eastern Tennessee and the third largest oncology practice in the state.

德克萨斯州伍德兰市——（商业新闻短讯）——美国肿瘤网络（THE Network）是致力于推进当地癌症护理和改善患者预后的同类最大组织，今天宣布，田纳西州癌症专家（TCS）已加入该网络，自2024年8月1日起生效。该机构是田纳西州东部最大的社区肿瘤学提供者，也是该州第三大肿瘤学机构。

With the addition of TCS, The Network significantly extends its reach into eastern Tennessee while the practice enhances its ability to provide cancer patients in the region convenient access to high-quality, cutting-edge cancer care..

随着TCS的加入，该网络大大扩展了其在田纳西州东部的影响力，同时该实践增强了其为该地区的癌症患者提供方便的高质量，尖端癌症护理的能力。。

“We are pleased to welcome Tennessee Cancer Specialists to The Network, as it allows us to collaborate with a well-known, long-standing provider of high-quality community-based cancer care,” said Devon Womack, president, The US Oncology Network. “We share like-minded goals to advance cancer care while strengthening the practice’s ability to remain independent and viable in today’s challenging value-based landscape.”.

美国肿瘤学网络总裁德文·沃马克（DevonWomack）表示：“我们很高兴欢迎田纳西州癌症专家加入该网络，因为它使我们能够与一家知名的、长期提供高质量社区癌症护理的提供商合作。我们有着共同的目标，以推进癌症护理，同时加强该机构在当今具有挑战性的价值观环境中保持独立和可行的能力。”。

As part of The Network, TCS can now utilize the deep expertise and substantial resources of The Network. The practice’s clinical staff can collaborate with their colleagues across The Network, tapping into the collective knowledge and experience of more than 2,600 independent providers across the U.S.

作为网络的一部分，TCS现在可以利用网络的丰富专业知识和大量资源。该机构的临床工作人员可以通过网络与同事合作，利用美国2600多家独立提供商的集体知识和经验。

The practice can also access The Network’s clinical and business consulting services, as well as innovative technologies that support high-quality patient care, efficient drug management, and revenue cycle optimization..

该机构还可以访问该网络的临床和商业咨询服务，以及支持高质量患者护理、高效药物管理和收入周期优化的创新技术。。

“We have had significant growth over the last few years, and we plan to continue this expansion by entering new markets, adding physicians, and building new service lines,” said Tracy W. Dobbs, MD, practice president, Tennessee Cancer Specialists. “The comprehensive resources and expert guidance from The Network will be invaluable as we move forward on this growth path while continuing to provide the high level of cancer care our patients and referring physicians have come to know and expect.”.

田纳西州癌症专家执业总裁、医学博士特雷西·多布斯（TracyW.Dobbs）说：“在过去几年中，我们取得了显著的增长，我们计划通过进入新市场、增加医生和建立新的服务线来继续这种扩张。”。“随着我们在这条增长道路上取得进展，同时继续为我们的患者和转诊医生提供高水平的癌症护理，来自网络的综合资源和专家指导将是非常宝贵的。”。

The Network is supported by McKesson Corporation, allowing TCS to benefit from a comprehensive suite of solutions and services. From access to Ontada’s cutting-edge technologies enabling enhanced patient referral, patient intake, and provider workflow as well as simplified genomic test ordering and result capture, to increased access to innovative clinical trial opportunities, McKesson’s unapparelled oncology portfolio can help community-based practices like TCS thrive, so they can best care for their patients..

该网络由McKesson Corporation提供支持，使TCS能够从一套全面的解决方案和服务中受益。从获得Ontada的尖端技术，增强患者转诊，患者摄入和提供者工作流程，简化基因组测试排序和结果捕获，到增加创新临床试验机会，McKesson未受欢迎的肿瘤学组合可以帮助社区为基础的实践，如TCS蓬勃发展，因此他们可以为患者提供最佳护理。。

As announced in May, the practice is especially eager to engage in clinical research through Sarah Cannon Research Institute (SCRI). Since its inception, SCRI has contributed to pivotal research that has helped advance the majority of new cancer therapies approved by the FDA today. In collaboration with SCRI, TCS will be able to provide patients convenient access to some of the most innovative investigational therapies in the communities where patients live..

正如5月宣布的那样，该机构特别渴望通过莎拉·坎农研究所（SCRI）进行临床研究。自成立以来，SCRI为关键研究做出了贡献，这有助于推进FDA今天批准的大多数新癌症疗法。通过与SCRI的合作，TCS将能够为患者提供方便的途径，使患者能够在患者居住的社区中获得一些最具创新性的研究疗法。。

“The stability, experience, resources, and professionalism of The Network drew us to the organization,” Dobbs stated. “We are excited to collaborate with this highly respected group of independent providers to achieve our mutual goal of bringing advanced cancer care to more communities.”

多布斯表示：“该网络的稳定性、经验、资源和专业性吸引了我们加入该组织。”。“我们很高兴与这个备受尊重的独立提供者团队合作，以实现我们的共同目标，将先进的癌症护理带给更多社区。”

TCS is the premier provider of advanced cancer care in eastern Tennessee with 15 physicians and 45 advanced practice providers (APPs) delivering world-class cancer care across 16 locations. The practice is committed to putting the patient first by delivering high-quality, compassionate, evidence-based care designed specifically to meet the unique needs of each patient.

TCS是田纳西州东部先进癌症护理的首要提供商，拥有15名医生和45名先进实践提供商（应用程序），在16个地点提供世界一流的癌症护理。该机构致力于为患者提供高质量、富有同情心、循证护理，以满足每位患者的独特需求。

A full-service, comprehensive medical oncology and hematology practice, TCS offers onsite infusion centers, cutting-edge clinical trials, on call 24/7 support, knowledgeable billing and insurance staff, financial counseling and patient assistance, plus in-office pharmacy services for added convenience.

TCS是一家提供全方位服务的综合性肿瘤学和血液学医疗机构，提供现场输液中心、尖端临床试验、全天候待命支持、知识渊博的计费和保险人员、财务咨询和患者援助，以及办公室药房服务，以增加便利。

The practice also provides non-oncology injections and infusions for patients who require specialty infusion services for other conditions, giving patients the convenience of dealing with one facility for all their infusion needs..

该机构还为其他情况下需要专业输液服务的患者提供非肿瘤注射和输液，使患者能够方便地处理一个设施的所有输液需求。。

The physicians and APPs of TCS are among many who have recently joined The Network. Within the last 18 months, The Network has welcomed more than 400 new providers into the organization. This continued growth trajectory is significantly increasing the availability of advanced cancer care in local communities from strong, viable, and independent practices..

TCS的医生和应用程序是许多最近加入该网络的人之一。在过去的18个月里，该网络已经欢迎了400多家新供应商加入该组织。这种持续的增长轨迹大大增加了当地社区从强大，可行和独立的实践中获得先进癌症护理的可能性。。

About Tennessee Cancer Specialists

关于田纳西州癌症专家

Tennessee Cancer Specialists, PLLC was founded in 2004 when East Tennessee Oncology and Hematology merged with Cancer Care of East Tennessee to become the largest private, independent cancer practice in eastern Tennessee and the third largest oncology group in the state of Tennessee. The practice has offices in eight counties to conveniently serve patients in Knoxville and surrounding communities.

田纳西州癌症专家，PLLC成立于2004年，当时东田纳西州肿瘤学和血液学与东田纳西州的癌症护理部门合并，成为田纳西州东部最大的私人独立癌症诊所，也是田纳西州第三大肿瘤学组。该机构在八个县设有办事处，方便地为诺克斯维尔及其周围社区的患者提供服务。

At Tennessee Cancer Specialists, their mission is to provide the highest quality compassionate care, to meet the unique needs of patients with cancer, and to assist them and their families to focus on recovery..

田纳西癌症专家的使命是提供最高质量的同情护理，满足癌症患者的独特需求，并帮助他们及其家人专注于康复。。

About The US Oncology Network

关于美国肿瘤学网络

Every day, The US Oncology Network (The Network) helps more than 2,600 independent providers deliver value-based, integrated care to patients — close to home. Through The Network, these independent doctors come together to form a community of shared expertise and resources dedicated to advancing local cancer care and to delivering better patient outcomes.

每天，美国肿瘤学网络（The Network）帮助2600多家独立提供者为患者提供基于价值的综合护理-离家不远。通过该网络，这些独立的医生聚集在一起，形成一个共享专业知识和资源的社区，致力于推进当地癌症护理并提供更好的患者结果。

The Network provides practices with access to coordinated resources, best business practices, and the experience, infrastructure, and support of McKesson Corporation. This collaboration allows the providers in The Network to focus on the health of their patients, while McKesson focuses on the health of their practices.

该网络为实践提供了获得协调资源、最佳商业实践以及McKesson Corporation的经验、基础设施和支持的途径。这种合作使网络中的提供者能够专注于患者的健康，而McKesson则专注于其实践的健康。

The Network is committed to the success of independent practices, everywhere..

该网络致力于在任何地方取得独立实践的成功。。

About McKesson Oncology and Specialty Solutions

关于McKesson肿瘤学和专业解决方案

It’s an unprecedented time for patients living with cancer as life sciences companies race to create new, cutting-edge therapies. With cancer care becoming more targeted, providers, life sciences companies, and payers face a multitude of challenges and complexity in the development of new treatments and making them accessible to patients in need.

对于癌症患者来说，这是一个前所未有的时代，因为生命科学公司正在争相创造新的尖端疗法。随着癌症护理越来越有针对性，提供者，生命科学公司和付款人在开发新疗法并使有需要的患者能够获得这些疗法方面面临着众多挑战和复杂性。

At McKesson, our unmatched portfolio of oncology businesses and partners provide research, insights, technologies, and services that are helping to address these hurdles and improve cancer and specialty care..

在麦凯森，我们无与伦比的肿瘤学业务和合作伙伴组合提供研究、见解、技术和服务，帮助解决这些障碍，改善癌症和专科护理。。

McKesson is fueling discovery by helping patients participate in cutting-edge clinical trials closer to home through the joint venture between US Oncology Research and Sarah Cannon Research Institute.

McKesson通过美国肿瘤学研究所和SarahCannon研究所的合资企业，帮助患者在离家较近的地方参与尖端临床试验，从而推动了这一发现。

The US Oncology Network and McKesson Provider Solutions are advancing specialty care and high-quality cancer care in the communities where patients live by supporting the practices of thousands of independent, community-based providers.

美国肿瘤学网络和McKesson提供者解决方案通过支持数千名独立的社区提供者的实践，正在患者居住的社区推进专科护理和高质量的癌症护理。

Ontada®, a McKesson business dedicated to oncology, generates real-world data (RWD) and real-world evidence (RWE), and provides clinical education and provider technology to inform and improve cancer care.

Ontada®是一家专注于肿瘤学的McKesson企业，它可以生成真实世界的数据（RWD）和真实世界的证据（RWE），并提供临床教育和提供者技术，以告知和改善癌症护理。

As one of the largest distributors of oncology and specialty medicines, we are ensuring medicines make their way to those who are counting on them.

作为最大的肿瘤学和特种药物分销商之一，我们正在确保药物能够流向那些依赖它们的人。

And through CoverMyMeds, Biologics by McKesson, and GPO services, our work continues to help patients access, afford, and adhere to their medicines.

通过CoverMyMeds、McKesson的生物制剂和GPO服务，我们的工作继续帮助患者获得、负担和坚持他们的药物。